Predictive Factors for Primary and Secondary Nonresponse to Upadacitinib Therapy Among Patients With Moderate to Severe Atopic Dermatitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Predictive Factors for Primary and Secondary Nonresponders to Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis: A Real-World Study
Dermatitis 2024 Dec 05;[EPub Ahead of Print], T Hagino, H Saeki, E Fujimoto, N KandaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.